Cargando…
Nanoparticles: a breakthrough in COVID-19 prevention, diagnosis and treatment
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), declared a global pandemic by the World Health Organization (WHO). The three key principles in management of the COVID-19 pandemic are prevention, early detection and...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507787/ https://www.ncbi.nlm.nih.gov/pubmed/37732058 http://dx.doi.org/10.5114/aoms/142103 |
_version_ | 1785107389288022016 |
---|---|
author | Skwarek, Aleksandra Gąsecka, Aleksandra Jaguszewski, Miłosz J. Szarpak, Łukasz Dzieciątkowski, Tomasz Filipiak, Krzysztof J. |
author_facet | Skwarek, Aleksandra Gąsecka, Aleksandra Jaguszewski, Miłosz J. Szarpak, Łukasz Dzieciątkowski, Tomasz Filipiak, Krzysztof J. |
author_sort | Skwarek, Aleksandra |
collection | PubMed |
description | Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), declared a global pandemic by the World Health Organization (WHO). The three key principles in management of the COVID-19 pandemic are prevention, early detection and targeted treatment. Vaccine-based prevention together with early detection has already proven its efficacy in controlling the pandemic. Early detection of infected patients could substantially accelerate the implementation of treatment, but also help to identify infection hotspots, whereas targeted treatment might destroy the virus and minimize damage to healthy tissue. Nanoparticles hold great promise with respect to these aspects. They may also be the solution to emerging clinical problems such as reinfection, pregnancy-related COVID-19 and coinfection. Here, we aim to discuss the potential applications of nanoparticles to combat the COVID-19 pandemic. |
format | Online Article Text |
id | pubmed-10507787 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Termedia Publishing House |
record_format | MEDLINE/PubMed |
spelling | pubmed-105077872023-09-20 Nanoparticles: a breakthrough in COVID-19 prevention, diagnosis and treatment Skwarek, Aleksandra Gąsecka, Aleksandra Jaguszewski, Miłosz J. Szarpak, Łukasz Dzieciątkowski, Tomasz Filipiak, Krzysztof J. Arch Med Sci State of the Art Paper Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), declared a global pandemic by the World Health Organization (WHO). The three key principles in management of the COVID-19 pandemic are prevention, early detection and targeted treatment. Vaccine-based prevention together with early detection has already proven its efficacy in controlling the pandemic. Early detection of infected patients could substantially accelerate the implementation of treatment, but also help to identify infection hotspots, whereas targeted treatment might destroy the virus and minimize damage to healthy tissue. Nanoparticles hold great promise with respect to these aspects. They may also be the solution to emerging clinical problems such as reinfection, pregnancy-related COVID-19 and coinfection. Here, we aim to discuss the potential applications of nanoparticles to combat the COVID-19 pandemic. Termedia Publishing House 2021-10-15 /pmc/articles/PMC10507787/ /pubmed/37732058 http://dx.doi.org/10.5114/aoms/142103 Text en Copyright: © 2021 Termedia & Banach https://creativecommons.org/licenses/by-nc-sa/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license. |
spellingShingle | State of the Art Paper Skwarek, Aleksandra Gąsecka, Aleksandra Jaguszewski, Miłosz J. Szarpak, Łukasz Dzieciątkowski, Tomasz Filipiak, Krzysztof J. Nanoparticles: a breakthrough in COVID-19 prevention, diagnosis and treatment |
title | Nanoparticles: a breakthrough in COVID-19 prevention, diagnosis and treatment |
title_full | Nanoparticles: a breakthrough in COVID-19 prevention, diagnosis and treatment |
title_fullStr | Nanoparticles: a breakthrough in COVID-19 prevention, diagnosis and treatment |
title_full_unstemmed | Nanoparticles: a breakthrough in COVID-19 prevention, diagnosis and treatment |
title_short | Nanoparticles: a breakthrough in COVID-19 prevention, diagnosis and treatment |
title_sort | nanoparticles: a breakthrough in covid-19 prevention, diagnosis and treatment |
topic | State of the Art Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507787/ https://www.ncbi.nlm.nih.gov/pubmed/37732058 http://dx.doi.org/10.5114/aoms/142103 |
work_keys_str_mv | AT skwarekaleksandra nanoparticlesabreakthroughincovid19preventiondiagnosisandtreatment AT gaseckaaleksandra nanoparticlesabreakthroughincovid19preventiondiagnosisandtreatment AT jaguszewskimiłoszj nanoparticlesabreakthroughincovid19preventiondiagnosisandtreatment AT szarpakłukasz nanoparticlesabreakthroughincovid19preventiondiagnosisandtreatment AT dzieciatkowskitomasz nanoparticlesabreakthroughincovid19preventiondiagnosisandtreatment AT filipiakkrzysztofj nanoparticlesabreakthroughincovid19preventiondiagnosisandtreatment |